Beige differentiation of adipose depots in mice lacking prolactin receptor protects against high fat diet-induced obesity
While PRL is known
as the pituitary hormone of lactation, accumulating
evidence shows that it exerts pleiotropic effects including growth and
metabolic actions (2,3). Here, we demonstrate that PRLR is an
important effector modulating adipocyte fate and differentiation with impact on
energy homeostasis and adaptive thermogenesis.
Despite
increased food intake in both SC and HFD, PRLR-/- mice remained
leaner than controls and were protected against HFD-induced obesity with a
marked reduction in adiposity, notably in perirenal fat mass. Thus, we
hypothesized that change in overall energy expenditure may be at least in part
responsible for this phenotype. This was supported by increased O2 consumption
and enhanced heat dissipation that were significantly higher in PRLR-/-
mice as compared to PRLR+/+ mice. The relative resistance to
HFD-induced obesity was accompanied by a more favorable carbohydrate
homeostatic profile in PRLR-/- mice, consistent with the major
implication of PRL signaling in energy balance. However, these changes in whole
body homeostasis were likely not sufficient to account for the robust
protection against HFD-induced weight gain. Increased energy expenditure
through BAT activation constitutes a powerful mechanism by which
high calorie intake could be dissipated, thereby defending against obesity (27). Indeed, enhanced conversion
of white to thermogenically active adipocytes observed in PRLR-/-
mice seems to be the key regulatory event involved in protection against
HFD-induced obesity, consistent with a role of PRL signaling in adipocyte fate
determination and/or reprogramming.
In accordance with PRL-mediated transcriptional
control of proadipogenic factors (11), PRLR deficiency was associated with a down-regulation
of key regulators of adipocyte differentiation, whose expressions were restored
to similar extent than in WT mice under HFD. Beyond this HFD-induced rescue
observed in PRLR-/- mice, the most striking finding is the emergence
of BAT within white adipose depots. The
question of where beige cells originate remains unresolved. It has been proposed
that the adaptive UCP1-expressing brown-like adipose cells that develop in WAT
in response to cold exposure or beta-adrenergic stimulation can be derived
either from a specialized compartment of committed brown precursors, direct
differentiation from white preadipocytes, and/or transdifferentiation from
mature white adipocytes (28). Regardless of how they arise and the origin of mesenchymatous
precursors (often referred to as Myf5- and Sca1+ progenitors)
(29,30), the development of beige adipocytes (17) in perirenal fat tissue correlates well with protection against
obesity in PRLR-/- mice. New advances in identification of cellular lineage
specification have highlighted several key regulatory factors in specifying brown
fat cell fate including PRMD16, a master co-regulator critical for the
commitment towards brown adipocyte lineage (31,32). Loss of PRDM16 from brown fat precursors caused a
massive reduction in molecular and morphological features of brown adipocytes (33). Conversely, transgenic overexpression of PRDM16
strongly induced the development of brown-like adipocytes in adipose depots (22). Remarkably, under HFD, PRMD16 expression is
dramatically induced in the perirenal fat depots as well as in the subcutaneous
white fat, associated with a concomitant increase of BAT markers. This is
supported by the emergence of UCP1-expressing adipocytes and metabolically
active beige cells located in the perirenal and paraspinal areas accounting for
the increased metabolic rate in absence of PRLR. Accordingly, PRLR-/-
mice displayed an increased of AdRb3 expression,
suggesting that PRL signaling may affect sympathetic nervous system activity
and/or nerve fibers infiltration in fat depots. Altogether, these findings
demonstrate that PRLR inactivation could lead to the emergence of
inducible-brown adipocytes and its associated thermogenesis. Remarkably, this
beige reprogramming is genetically determined (markedly in PRLR-/-
mice), induced under HFD and more pronounced in specific fat depots. By
contrast, the presence of an active PRL signaling could participate to the
white adipocyte phenotype maintenance of these fat depots. One question concerns
the signaling molecules involved in acquisition of a brown adipose-like
phenotype in perirenal depots. pRb has been suggested to regulate adipocyte
differentiation (34). In addition, p107, a member of Rb family, is also
implicated in adipose development. P107-/- mice are refractory to
HFD-induced fat accumulation associated with an increase of PGC1a expression (34). Consistently, marked decrease of pRb
expression was found in mice deficient in fsp27, a member of the cide family protein regulating adipose
tissue differentiation (35). Gonadal and subcutaneous white fat pads of Fsp27-/-
mice are reduced in size compared to wild type mice, together with the
acquisition of BAT-like phenotype (35). Collectively, these findings underscore the
implication of pRb pathway in adipocyte fate, in accordance with the pRb defect
observed in PRLR-/- fat depots. It was shown that pRb-deficient mouse embryonic fibroblasts exhibited an
increased expression of the Forkhead transcription factor Foxc2 that
accompanied a white to brown adipocyte transdifferentiation (36). Similarly, overexpression of Foxc2 in
adipose tissue leads to a lean and insulin-sensitive phenotype accompanied by
an increased BAT-like function due to an enhanced mitochondrial biogenesis
through activation of mitochondrial transcription factors (26,37). PRLR-/- mice under HFD displayed a sharp
increase in Foxc2 expression, in agreement with the involvement of
pRb/Foxc2 pathway in the “beigeing” conversion.
The functional role of PRL signaling seems to be
highly dependent upon the developmental stage. Indeed, we have demonstrated
that PRLR is pivotal for early development of BAT to support neonatal
thermogenesis (14). In contrast, during adulthood, the absence of PRL
signaling is associated with beige conversion, most notably as an adaptive
mechanism to facilitate high fat-induced thermogenesis. Thus, PRL signaling
plays important but changing roles in energy homeostasis during the lifespan.
This is reminiscent of the metabolic action of PRL reported in amphibians (38), fish and birds (1) but far extends the pleiotropic function of PRL in
mammals. From a metabolic point of view, PRL is critical during gestation and
lactation, favoring anabolic lipid storages indispensable for energy needs
during these two major physiological periods. Several lines of evidence suggest
that in humans, PRL signaling could be involved in energy homeostasis including
the orexigenic property of PRL (39,40), the genetic association between PRL and obesity (41,42) and the relationship between hyperprolactinemia and
obesity (43,44). Several recent reports confirmed the major role of
BAT in the control of energy balance. Thermogenic UCP1-expressing cells are
found interspersed in adult human subcutaneous fat yet their presence negatively
correlates with weight gain and insulin resistance (45-49). It would be relevant to examine whether patients
with hyperprolactinemia are less prone to develop a functional BAT in response
to cold exposure or overfeeding using PET.
In sum, our work demonstrates that mice lacking PRLR are highly
resistant to HFD-induced obesity, owing to the emergence of a brown
adipose-like phenotype in peculiar white fat depots. This is associated with a
concomitant increase of PRDM16, PGC1a, AdRb3 and Foxc2
that constitutes a molecular switching mechanism. This in turn converges
towards an activation of thermogenic brown capacity with the final increase of
UCP1 responsible for heat dissipation and resistance to high calorie weight
gain. We thus propose that PRL signaling represents an additional determinant
of energy homeostasis during physiological and pathophysiological conditions.
Post Comment
No comments